uk's nice backs roche drug as maintenance therapy
roche's cancer drug mabthera has been recommended for use on britain's state health service as a maintenance therapy for patients with follicular non-hodgkin's lymphoma, expanding the market for the medicine.
http://feeds.reuters.com/~r/reuters/healthnews/~3/fudpebpijiy/us-roche-britain-idustre74m6wz20110523
2812
24 May 2011 01:11:51
reuters
health